Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
A private biopharmaceutical company .
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Visus Therapeutics is a clinical-stage company developing innovative medicines.
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Swift Health Systems is a stealth stage start-up medical device company, developing INBRACE.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
AIRNA develops RNA editing technologies to create medicines for various diseases.
Prolium is a biotechnology company, which specializes in providing breakthrough therapies to the patients with autoimmune diseases.
Amani uses cutting-edge research to break down barriers and provide people with severe mental illness with efficient treatments.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
RTW Investments has invested in 107 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RTW Investments's top investment sectors include Biotechnology, Health Care, Biopharma, Medical, Therapeutics. The firm invests across 15 different industry categories.
Among tracked funding rounds, Oruka Therapeutics received $700.4M in a Post-IPO Equity round. RTW Investments's total known invested capital is $11.5B.
RTW Investments's average investment size is $139.0M across its portfolio of 107 companies.
Recent RTW Investments portfolio additions include Renovacor, ACELYRIN, Neurogastrx, Frequency Therapeutics, Visus Therapeutics. These companies were founded in 2020 or later.